Soigner le cancer via mRNA ce serait énorme !
BioNTech has announced that it has commenced dosing in it's BNT111 Phase II cancer vaccine trial in advanced melanoma.
via Thomas’s Innovation Wrap : lire l’article source
First patient dosed in BioNTech Phase II trial of mRNA cancer vaccine
Encausse.net 
Laisser un commentaire